TESARO

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Enedra Therapeutics Ltd

This company develops precision medicines and biomarkers to treat advanced, genetically heterogeneous cancers for patients with drug-resistant tumours.

ArriVent

This biopharmaceutical company develops and commercialises oncology therapeutics, including targeted medicines and antibody-drug conjugates, to treat patients with difficult-to-treat cancers globally.

Nuvation Bio

This biopharmaceutical company develops and commercialises targeted oncology therapies for patients with cancers that have unmet medical needs.

Olema Oncology

This biopharmaceutical company develops targeted therapies, including palazestrant, for women diagnosed with estrogen receptor-positive breast cancer and other solid tumours.

Juno Therapeutics

This biopharmaceutical company develops immunotherapies using genetically engineered cells to treat patients with various types of cancer.

Blueprint Medicines

This biopharmaceutical company develops and commercialises kinase inhibitors for patients with systemic mastocytosis, gastrointestinal stromal tumours and other genomic-driven cancers.

Avenzo Therapeutics

This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.